BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Prognosis
47 results:

  • 1. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
    Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
    [No Abstract]    [Full Text] [Related]  

  • 2. CircRNA CircABCB1 Diminishes the Sensitivity of breast cancer Cells to Docetaxel by Sponging MiR-153-3p.
    Liu J; Kong L; Bian W; Lin X; Wei F; Chu J
    Tohoku J Exp Med; 2023 Sep; 261(1):25-33. PubMed ID: 37164696
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer.
    Takada K; Kashiwagi S; Iimori N; Kouhashi R; Yabumoto A; Goto W; Asano Y; Tauchi Y; Morisaki T; Ogisawa K; Shibutani M; Tanaka H; Maeda K
    BMC Cancer; 2023 Mar; 23(1):224. PubMed ID: 36894884
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mammographic Density Reduction is Associated to the prognosis in Asian breast cancer Patients Receiving Hormone Therapy.
    Shia WC; Lin LS; Wu HK; Chen CJ; Chen DR
    Cancer Control; 2023; 30():10732748231160991. PubMed ID: 36866691
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma.
    Ma S; Ge Y; Xiong Z; Wang Y; Li L; Chao Z; Li B; Zhang J; Ma S; Xiao J; Liu B; Wang Z
    PeerJ; 2023; 11():e14784. PubMed ID: 36785707
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic Impact of Smoking on Bevacizumab Combination Chemotherapy for Advanced breast cancer.
    Takada K; Kashiwagi S; Iimori N; Kouhashi R; Yabumoto A; Goto W; Asano Y; Tauchi Y; Ogisawa K; Morisaki T; Shibutani M; Tanaka H; Maeda K
    Anticancer Res; 2023 Feb; 43(2):849-856. PubMed ID: 36697094
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effects of exercise on inflammatory factors and IGF system in breast cancer survivors: a meta-analysis.
    Zhou Y; Jia N; Ding M; Yuan K
    BMC Womens Health; 2022 Dec; 22(1):507. PubMed ID: 36482346
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Intratumoral heterogeneity contributes to the chemotherapy prognosis of breast cancer.
    Li Y; Wang M; Yang S; Kuang L; Tao X; Yang J; Zhao W; Zhang J
    J Cancer Res Ther; 2022 Sep; 18(5):1268-1275. PubMed ID: 36204872
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.
    Raffone A; Travaglino A; Raimondo D; Neola D; Maletta M; Santoro A; Insabato L; Casadio P; Fanfani F; Zannoni GF; Zullo F; Seracchioli R; Mollo A
    Gynecol Oncol; 2022 Apr; 165(1):192-197. PubMed ID: 35078650
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical observation of palbociclib combined with endocrine therapy in hormone receptor positive and HER2 negative advanced breast cancer].
    Lyu HM; Niu LM; Zhang MW; Zeng HA; Zhao SN; Liu ZZ; Yan M
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(44):3625-3630. PubMed ID: 34823278
    [No Abstract]    [Full Text] [Related]  

  • 11. Associations of low handgrip strength with cancer mortality: a multicentre observational study.
    Zhuang CL; Zhang FM; Li W; Wang KH; Xu HX; Song CH; Guo ZQ; Shi HP
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1476-1486. PubMed ID: 32910535
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
    Guo L; Chen B; Zhang G; Wang Y; Cao L; Ren C; Wen L; Lin J; Wei G; Liao N
    Gene; 2020 Oct; 759():144970. PubMed ID: 32711101
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
    Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer.
    Kurahara H; Maemura K; Mataki Y; Tanoue K; Iino S; Kawasaki Y; Idichi T; Arigami T; Mori S; Shinden Y; Higashi M; Ueno S; Shinchi H; Natsugoe S
    Pancreatology; 2020 Jan; 20(1):89-94. PubMed ID: 31787525
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evaluation of Therapeutic Target Gene Expression Based on Residual cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative breast cancer.
    Takahashi Y; Iwamoto T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kawada K; Kochi M; Ikeda H; Shien T; Taira N; Matsuoka J; Doihara H; Toyooka S
    Clin Breast Cancer; 2020 Apr; 20(2):117-124.e4. PubMed ID: 31570267
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
    Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
    Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence].
    Cowppli-Bony A; Colonna M; Ligier K; Jooste V; Defossez G; Monnereau A; ;
    Bull Cancer; 2019; 106(7-8):617-634. PubMed ID: 30833045
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A single-center study on total mastectomy versus skin-sparing mastectomy in case of pure ductal carcinoma in situ of the breast.
    Lhenaff M; Tunon de Lara C; Fournier M; Charitansky H; Brouste V; Mathoulin-Pelissier S; Pinsolles V; Rousvoal A; Bussieres E; Chassaigne F; Croce S; Ben Rejeb H; MacGrogan G
    Eur J Surg Oncol; 2019 Jun; 45(6):950-955. PubMed ID: 30683448
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
    Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Lee HB; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
    Breast Cancer Res Treat; 2019 May; 175(1):117-127. PubMed ID: 30671767
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. 1399 H&E-stained sentinel lymph node sections of breast cancer patients: the CAMELYON dataset.
    Litjens G; Bandi P; Ehteshami Bejnordi B; Geessink O; Balkenhol M; Bult P; Halilovic A; Hermsen M; van de Loo R; Vogels R; Manson QF; Stathonikos N; Baidoshvili A; van Diest P; Wauters C; van Dijk M; van der Laak J
    Gigascience; 2018 Jun; 7(6):. PubMed ID: 29860392
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.